Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00836043
What this trial is testing

Safety, Effectiveness and Patient Acceptance of the Treatment With MabCampath in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Genzyme, a Sanofi Company 6
Testing effectiveness (Phase 2)Ended earlyNCT02592876
What this trial is testing

Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma, B-cellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular, Grade 3b+1 more
Seagen Inc. 81
Testing effectiveness (Phase 2)Study completedNCT05347485
What this trial is testing

JNJ-68284528 Out-of-Specification (OOS) for Commercial Release in Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Scientific Affairs, LLC 86
Not applicableLooking for participantsNCT07258043
What this trial is testing

Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphobkastic LeukemiaLeukemiaOverall Survival
Hospital General de Mexico 45
Very early researchLooking for participantsNCT04227015
What this trial is testing

CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy

Who this might be right for
Acute Lymphoblastic LeukemiaNon-hodgkin Lymphoma
He Huang 72
Large-scale testing (Phase 3)Study completedNCT01033747
What this trial is testing

Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study

Who this might be right for
Liver Iron Overload
Novartis Pharmaceuticals 70
Not applicableLooking for participantsNCT05237258
What this trial is testing

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Who this might be right for
Relapsed Adult AMLPrimary Refractory Acute Myeloid LeukemiaHigh Risk Acute Myeloid Leukemia
Massachusetts General Hospital 2,300
Not applicableEnrolling By InvitationNCT05509855
What this trial is testing

A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Lymphoblastic Lymphoma
Allotera Therapeutics 44
Testing effectiveness (Phase 2)Study completedNCT00406978
What this trial is testing

Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Silvio Aime 24
Early research (Phase 1)Study completedNCT04626843
What this trial is testing

Intermittent Fasting and CLL/SLL

Who this might be right for
NeoplasmsLeukemia, Lymphocytic, ChronicLymphoma, Small Lymphocytic+3 more
Eleah Stringer 15
Very early researchStudy completedNCT01822015
What this trial is testing

Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)+11 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 55
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Large-scale testing (Phase 3)Study completedNCT00064038
What this trial is testing

S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
SWOG Cancer Research Network 198
Early research (Phase 1)Study completedNCT03009240
What this trial is testing

Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia+3 more
City of Hope Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT01630889
What this trial is testing

Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseEnd Stage Renal DiseaseAnemia
Kyntra Bio 15
Testing effectiveness (Phase 2)Study completedNCT00219752
What this trial is testing

Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years

Who this might be right for
Chronic Myeloid Leukemia
Poitiers University Hospital 30
Large-scale testing (Phase 3)Study completedNCT00699348
What this trial is testing

Monthly Intravenous C.E.R.A. (Mircera) in Hemodialysis Participants With Chronic Renal Anemia

Who this might be right for
Anemia
Hoffmann-La Roche 351
Large-scale testing (Phase 3)Study completedNCT02493335
What this trial is testing

Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis

Who this might be right for
Eosinophilic Esophagitis
Dr. Falk Pharma GmbH 204
Testing effectiveness (Phase 2)Study completedNCT02480608
What this trial is testing

Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004)

Who this might be right for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
University of Leipzig 113
Not applicableLooking for participantsNCT07250217
What this trial is testing

Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients

Who this might be right for
Acute Myeloblastic Leukemia
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace 30
Next Page